Thumbnail Image
Publication

Outcomes of patients presenting to a dedicated rapid access lung cancer clinic.

Dunican, E
; 
Uzbeck, M
; 
Clince, J
; 
Toner, S
; 
Royston, D
; 
Logan, M P
; 
Breathnach, O
; 
Young, V
; 
Linnane, S I
; 
Morgan, R K
Author
Dunican, E
 Uzbeck, M
 Clince, J
 Toner, S
 Royston, D
 Logan, M P
 Breathnach, O
 Young, V
 Linnane, S I
 Morgan, R K
Advisors
Editors
Other Contributors
Departments
Department of Respiratory Medicine and Thoracic Oncology, Beaumont Hospital,, Beaumont, Dublin 9.
Date
2012-02-01T10:03:26Z
Date Submitted
Keywords
Other Subjects
Subject Mesh
Adolescent
Adult
Aged
Aged, 80 and over
Carcinoma, Non-Small-Cell Lung/diagnosis/epidemiology/therapy
Combined Modality Therapy
Female
Humans
Ireland/epidemiology
Lung Neoplasms/*diagnosis/epidemiology/*therapy
Male
Mesothelioma/diagnosis/epidemiology/therapy
Middle Aged
Neoplasm Staging
*Outpatient Clinics, Hospital
Prospective Studies
Small Cell Lung Carcinoma/diagnosis/epidemiology/therapy
Young Adult
Planned Date
Start Date
Collaborators
Principal Investigators
Files
Thumbnail Image
Article6383.pdf
Adobe PDF, 11.03 KB
Alternative Titles
Publisher
URI
https://hdl.handle.net/10147/207263
Abstract
We examined the outcomes of the first 500 patients referred to a dedicated Rapid Access Lung Cancer Clinic. A total of 206 patients (41.2%) were diagnosed with a thoracic malignancy; 179 had primary lung cancer and 27 had secondary or other thoracic cancers. Pulmonary nodules requiring ongoing surveillance were found in a further 79 patients (15.8%). Of those patients found to have primary lung cancer, 24 (13.4%) had Small Cell and 145 (81%) had Non Small Cell Lung Cancer. In patients with Non small cell tumours, 26 (21.1%) were stage 1, 14 (11.4%) stage II, 37 (30.1%) stage III and 46 (37.4%) stage IV at diagnosis. For the 129 patients (72%) in whom the thoracic MDT recommended active treatment, primary therapy was surgical resection in 44 (24.6%), combined chemoradiation in 31 patients (17.3%), chemotherapy alone in 39 (21.8%) and radiation in 15 (8.4%).
Language
eng
Citation
Ir Med J. 2011 Oct;104(9):265-8.
ISSN
0332-3102 (Print)
0332-3102 (Linking)
eISSN
ISBN
DOI
PMID
22132593
PMCID
Sponsorships
Funding Sources
Funding Amounts
Grant Identifiers
Methodology
Duration
Ethical Approval